The rare disease company

Search for more information about CENTOGENE and its dedicated team of professionals. Find details of our accreditation, commitment to social responsibility and our collaboration partners. Discover the latest news, conferences and events we are attending, plus all our current career opportunities.

  1. About Us

Dedicated to improving the lives of patients every day

CENTOGENE is a worldwide leader in the field of genetic diagnostics for rare hereditary diseases - with the largest test portfolio worldwide. Testing samples from over 110 different countries allows CENTOGENE a unique insight into the epidemiological basis of hereditary disorders, which is crucial for interpreting results and transform it into medical reports.

The company firmly focuses on offering quality molecular genetic diagnostics, underlined by its multiple international accreditations (CAP, CLIA, ISO). Our in-depth medical expertise is supported by the application of cutting-edge technologies, including next generation sequencing, whole genome sequencing (CentoGenome®), whole exome sequencing (CentoXome®) and innovative biomarkers for selected diseases. CENTOGENE has developed a comprehensive mutation database (CentoMD®) that is pivotal to offering high-quality diagnostic reporting and medical interpretation; thoroughly interpreting each patient’s sequence data.

In addition to diagnostic services for individual patients, CENTOGENE is also a pivotal partner for numerous high-profile industrial companies worldwide.

CENTOGENE cares – Our social responsibility

Nowadays, companies realize more than ever the need to take a social responsibility and to give something back the society.

CENTOGENE recognizes its social obligation and is undertaking active and sustainable steps to make the world a better place. As a global leader in the field of clinical genetic diagnostics and interpretation of rare diseases, the health of the people lies in the middle of our hearts.

Read more

Meet our experts at upcoming conferences

No news available.

Become part of our team and start your career at CENTOGENE

Join our young and growing company - an international and innovative work environment awaits you in one of the world´s leading companies for rare hereditary diseases diagnostics.

SHOW VACANCIES AT CENTOGENE

Our business locations – Where to find us

CENTOGENE AG is one of the world's leading companies in the field of rare genetic disease diagnostics.

With our broad international network of experienced employees, we are able to offer a wide range of services and support in diverse local languages worldwide.

In collaboration with our partners, we continually develop and test new diagnostic techniques, and are therefore always able to offer you the latest and most effective solutions to your diagnostic challenges.

Rostock Headquarter

CENTOGENE AG
Am Strande 7
18055 Rostock
Germany

UAE Business Location

CENTOGENE FZ-LLC
Executive office No. 32 Floor 8
Aurora Tower, Dubai Media City
P.O.Box 500717
Dubai, U.A.E 

Austria Business Location

CENTOGENE GmbH
Mariahilfer Str. 36
1070 Vienna
Austria

Berlin Business Location

CENTOGENE AG
Zimmerstr. 69
10117 Berlin
Germany

India Business Location

CENTOGENE India Private Limited
107 Wegman's Business Park, Knowledge Park III,
Surajpur-Kasna Road, Greater NOIDA - 201308,
Uttar Pradesh
India

USA Business Location

CENTOGENE US, LLC
1500 District Avenue
Burlington, MA 01803
USA

Impression of the CentoNew construction site located in the city harbour of Rostock, May 2017
Construction site impressions, January 2017
Video impressions from the construction site, October 2016

Construction site impressions, September 2016
Foundation Stone Ceremony, August 23, 2016
Groundbreaking ceremony, September 30, 2015

CentoNew

Our new headquarter in Rostock will greatly expand our laboratory facilities, with innovative architecture providing a working environment that stimulates productivity, creativity and exchanges of knowledge and ideas. This is crucial to fulfill our mission to play a central role in the new era of personalized medicine, striving to improve healthcare for patients. The impressive new CENTOGENE HQ will incorporate laboratories, offices and a fabulous public area that stretches 4,500m² with great views right across the river Warnow.

CENTOGENE has received funding from European Regional Development Fund.

ROSTOCK, GERMANY, April 10, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners,...

Read more

Dr. Anton Mamin has recently started his new position being responsible for strategic guidance to clinical trial growth and worldwide patient recruitment for...

Read more

CENTOGENE´s Chief Financial Officer, Richard Stoffelen, is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference in Boston...

Read more

There are more than 7,000 rare diseases where about 80% are hereditary. About 30 million Americans are living with a rare disease today; worldwide more than 350...

Read more

We mark Rare Disease Day 2018 with continued commitment to reduce time to diagnosis of rare diseases.

CENTOGENE has published a scientific paper that further...

Read more

Prof. Arndt Rolfs has joined newly formed “The Global Commission to End the Diagnostic Odyssey for Children”, a dedicated group of technology innovators,...

Read more

One of the website for rare disease community - Rare Disease Report has shared exciting news about CentoMD® mutation database milestone - one billion collected...

Read more

Rostock, Germany, February 1, 2018CENTOGENE, the worldwide leader in diagnosing, profiling, tracking and elucidating rare diseases for patients, clinicians...

Read more

With genomic information and clinical data amassed from more than 200,000 analyzed cases worldwide, CENTOGENE helps transform genetic information into medical...

Read more